play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
chevron_left
  • cover play_arrow

    Atlantic 195 Atlantic 195

News

The U.S. secretary of state cuts his Asia trip short after a journalist on his plane tests positive.

todayDecember 15, 2021

Background
share close

KUALA LUMPUR, Malaysia — Secretary of State Antony J. Blinken cut short his trip to Southeast Asia on Wednesday after a journalist traveling in his delegation tested positive for the coronavirus.

A State Department spokesman said Mr. Blinken has tested negative at every stop on diplomatic visits over the past week to Britain, Indonesia and Malaysia. He had scheduled meetings for Thursday with senior officials in Bangkok, the Thai capital, but canceled to return to the United States.

Ned Price, the State Department spokesman, said Mr. Blinken had called the Thai deputy prime minister, Don Pramudwinai, to “express his deep regret” over the change in plan.

“He explained that in order to mitigate the risk of the spread of Covid-19 and to prioritize the health and safety of the U.S. traveling party, and those they would otherwise come into contact with, the secretary would be returning to Washington, D.C., out of an abundance of caution,” Mr. Price said in a statement as the delegation was leaving Kuala Lumpur.

The journalist who tested positive for the virus was part of the small group of news media personnel who travel with the secretary of state. The journalist, who was not identified for privacy reasons, tested negative in Jakarta on Monday but then received a positive test for the virus after arriving in Kuala Lumpur, the Malaysian capital, on Tuesday night.

Mr. Price said the journalist who tested positive would remain in Kuala Lumpur for mandatory isolation while the rest of Mr. Blinken’s entourage traveled on.

Foreign governments have stepped up testing requirements for traveling diplomatic delegations as the Delta and Omicron variants have surged around the world.

Original story from https://www.nytimes.com

Written by: admin

Rate it

Previous post

News

Two Doses of China’s Sinovac Inadequate Against Omicron, Hong Kong Study Suggests

A new study looking at blood samples from people who received two doses of a Covid-19 vaccine made by the Chinese pharmaceutical company Sinovac suggested that the vaccine would be unable to prevent an infection of the new, highly infectious Omicron variant.The research, which analyzed the blood of 25 people vaccinated with Sinovac, is the latest sign of the new challenge Omicron presents as it spreads across the world. The […]

todayDecember 15, 2021


0%